Efficacy and safety of Org OD 14 in the treatment of climacteric complaints-Reference-Cited by-同舟云学术

Efficacy and safety of Org OD 14 in the treatment of climacteric complaints

Published:1983-08 Issue:2 Volume:5 Page:89-96
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Trévoux R.,Dieulangard P.,Blum A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,General Biochemistry, Genetics and Molecular Biology

Reference12 articles.

1. Oestrogen therapy and the menopausal syndrome;Campbell;Clin Obstet Gynaecol,1977

2. De Visser J, Coert A, Feenstra H, Van der Vies J. Endocrinological studies with (7a,17a)-7-methyl-19-norpregn-5(10)-en-20-yn-3-one, (Org. OD 14); submitted for publication.

3. Prospective double-blind trial of synthetic steroid (Org. OD 14) for preventing post-menopausal osteoporosis;Lindsay;Br Med J,1980

4. Placebo-controlled cross-over study of effects of Org. OD 14 in menopausal women;Kicovic;Reproduccion,1982

5. Uso de un nuevo estroide (Tibolone-Org. OD 14) en el sindrome climacterico;Cittadini;Reproduccion,1982

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites;The Journal of Steroid Biochemistry and Molecular Biology;2009-08

2. Treatment of hereditary angioneurotic oedema (HANE) with tibolone;Clinical Endocrinology;2007-02

3. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness;Maturitas;2006-03

4. Terapêutica com tibolona em mulheres diabéticas na pós-menopausa: parâmetros clínicos e laboratoriais de segurança;Arquivos Brasileiros de Endocrinologia & Metabologia;2005-06

5. Endometrial assessment in women using tibolone or placebo: 1-year randomized trial and 2-year observational study;Menopause;2004-07